ArticleDiscover oncology2022

KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway.

Xinran Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.